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1. Introduction 
Like other phospholipases, phospholipase C is a 
popular tool for investigating the relationship between 
membrane phospholipids and proteins. We were 
interested in investigating the possible involvement of 
polar headgroups of microsomal phospholipids in
maintaining the native conformations of cytochromes 
P-450 and b5 and in binding these proteins to the 
membrane of the endoplasmic reticulum. We are also 
interested in the possibility of solubilizing cytochrome 
P-450 by treating microsomes first with phospholipase 
C and then with a lipase, a procedure which would 
hydrolyze membrane phospholipids without at any 
time producing lysolecithin, a powerful detergent which 
denatures cytochrome P-450 [1 ] (J. DePierre, 
unpublished observations). 
2. Materials and methods 
Microsomes were prepared from the livers of 
180-200 g male Sprague-Dawley rats by the method 
of Ernster et al. [2]. In the experiments shown these 
rats received an intraperitoneal injection of 80 mg/kg 
phenobarbital once a day for three days before sacrifice; 
similar but less pronounced effects were seen with 
uninduced animals. Rough and smooth microsomes 
were separated according to Dallner [3]. When total, 
rough, or smooth microsomes were treated with 
phospholipase C (CI. welchii Sigma), the medium 
contained 50 mM Tris, pH 7.5, 2.0 mM CaC12. 
3-6 mg protein/ml and 100-150/~g phospholipase/mg 
microsomal protein. Treatment with crude pancreatic 
lipase (Sigma) was carried out under the same conditions 
except hat in addition to 1 mg lipase/mg microsomal 
protein, the medium also contained 1mg trypsin 
inhibitor/rag lipase in order to inhibit the trypsin which 
contaminates the lipase preparation. Incubations were 
carried out at 23°C and stopped by adding EDTA to 
give a final concentration f 10 mM and placing the 
tubes in ice. 
Cytochromes P-450, P-420, and bs were measured 
by the method of Omura and Sato [4]. The hydrolysis 
of phospholipids was determined by extracting the 
remaining phospholipids into chloroform-methanol 
[5] and determining the remaining lipid phosphorus 
according to Bartlett [6]. The control incubations 
(zero-time incubation, incubation for 30 rain without 
phospholipase C, incubation for 30 min without 
phospholipase C in the presence of 20 mg/ml fatty 
acid-free bovine serum albumin (BSA) (Sigma) and 
incubation for 30 min with phospholipase C and l0 mM 
EDTA) all gave values of 2.8 nmol cytochrome P-450, 
1.1 nmol cytochrome bs, and 600 nmol lipid phosphorus 
per mg microsomal protein. Solubilized was defined as 
remaining in the supernatant after centrifugation at
100 000 g for 1 hr. 
3. Results and discussion 
Fig. 1 shows that treatment of microsomes with 
phospholipase C has no effect on the content of 
cytochrome bs. On the other hand, fig.2 shows that 
such treatment causes aloss of some 55% of the 
microsomal cytochrome P-450. The amount of 
cytochrome P-450 that was converted to cytochrome 
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Fig.1. The effect of phospholipase C treatment on cytochrome 
b s. Microsomes were treated with phospholipase C and 
cytoehrome b 5 was measured as described in the Methods. All 
points are from a single or the average of two experiments, 
except for the points at 30 min, which represent the average 
and range of 5 determinations. (o)Treatment in the absence 
of BSA. (o) Treatment in the presence of 20 mg/ml fatty 
acid-free BSA. 
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Fig.2. The effect of phospholipase C treatment on cytochrome 
P-450. Microsomes were treated with phospnolipase C and 
cytochromc P-450 was measured as described in the Methods. 
All points are from a single or the average of two experiments, 
except for the points at 30 min, which represent the average 
and range of 5 determinations. (e)Treatment in the absence of 
BSA. (o) Treatment in the presence of 20 mg/ml fatty acid-free 
BSA. 
P-420 was highly variable, ranging between 25 and 
50%. Anaerobiosis or the presence of 10 mM amino- 
pyrine (a substrate of the cytochrome P-450 system), 
10 mM dithionite (which reduces the cytochrome), or
30% glycerol did not prevent the denaturation of cyto- 
chrome P-450 caused by phospholipase C treatment. 
Since it is known that rmcrosomes contain a 
diglyceride lipase activity that rapidly breaks down the 
diglycerides that are products of phospholipase C 
hydrolysis [7], it seemed possible that cytochrome 
P-450 was being denatured by free fatty acids rather 
than as a direct result of phospholipase C action. Indeed, 
fig.2 shows that 20 mg/ml fatty acid-free BSA prevented 
almost all of the denaturation. Half as much BSA 
afforded significantly less protection, while twice as 
much did not afford any more protection. Addition 
of BSA after phospholipase C treatment did not reverse 
the denaturation of cytochrome P-450. Fig. 1 shows 
that the presence of BSA in the medium during 
phospholipase C treatment resulted in denaturation 
of about 30% of cytochrome bs, a finding for which 
we have no ready explanation. 
It is, of course, possible that BSA prevents denatura- 
tion of cytochrome P-450 by inhibiting breakdown 
of the microsomal membrane by phospholipase C. 
That this is not the case is illustrated in fig.3: 70% of 
the microsomal phospholipids are hydrolyzed by 
phospholipase C both in the absence and presence 
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Fig.3. Hydrolysis of microsomal phospholipids by phospholipase 
C. Microsomes were treated with phospholipase C and the 
remaining lipid phosphorus was determined asdescribed in the 
Methods. All points are from a single or the average of two 
experiments, except for the points at 30 rain, which represent 
the average and range of 5 determinations. (e)Treatment in 
the absence of BSA. (o) Treatment in the presence of 20 mg/ml 
fatty acid-free BSA. 
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of BSA. In order to further test the explanation that 
BSA protects cytochrome P-450 by binding free fatty 
acids, microsomes were treated with pancreatic lipase 
to hydrolyze the membrane glycerides [8j and produce 
large amounts of free fatty acids. As depicted in 
table 1, this procedure denatured 92% of the cyto- 
chrome P-450; and 80% of this could be measured as 
cytochrome P-420. BSA was able to prevent more 
than one-half of this denaturation. Pancreatic lipase 
treatment had no effect on cytochrome bs. 
It was found that approximately 10% of the 
microsomal protein but no cytochrome P-450 or bs 
was solubilized by phospholipase C treatment. And 
finally, it seemed possible that phospholipase C might 
have different effects on the phospholipids and cyto- 
chrome P-450 of rough and smooth microsomes, due 
to a protection of the membrane surface by ribosomes, 
to different levels of diglyceride lipase activity, or to 
some other difference between these two microsomal 
subfractions. Table 1 demonstrates that this was not 
the case. 
The conclusions which can be drawn from this 
study are as follows: Neither the conformations of
cytochrome P-450 and bs in situ nor the binding of 
these proteins to the microsomal membrane is 
critically dependent on the polar headgroups of the 
70% of microsomal phospholipids that can be 
hydrolyzed by phospholipase C (Cl. welchii). This 70% 
includes 80% of the phosphatidylcholine and sphingo- 
myelin, 50% of the phosphatidylethanolamine, a d 
40% of the phosphatidylserine and phosphatidylinositol 
[9,10]. 
Cytochrome P-450 can be denatured by free fatty 
acids produced in situ. Glucose 6-phosphatase i  
another microsomal enzyme that can be denatured in 
the same manner [7]. The erythrocyte membrane, 
liver plasma membrane, muscle microsomes, and myelin 
of rats are all known to contain diglyceride lipase 
activity [ 11 ] ; and investigators should in general be 
aware of the danger of denaturing membrane enzymes 
by providing substrate for this activity, e.g., by 
phospholipase C treatment of the membrane. It has 
also been observed that high levels of laurate added to 
the medium denature cytochromeP-450 to cyto- 
chrome P-420 [12]. 
It has been reported that phospholipase C treatment 
of microsomes strongly inhibits type I metabolism 
catalyzed by the cytochrome P-450 system (e.g., 
aminopyrine demethylation) but does not affect or 
only slightly inhibits type I1 metabolism (e.g., aniline 
hydroxylation) [ 10,13,14]. These findings may be 
partially explained by the results hown in fig.2, which 
suggest that about one-half of the cytochrome P-450 
pool is more sensitive to free fatty acids than the other 
half. It is becoming more and more clear that cyto- 
chrome P-450 is a family of proteins; and it is possible 
that the cytochrome P-450 species involved in type I 
metabolism is more sensitive to denaturation by free 
fatty acids produced in situ than is the species involved 
in type II metabolism. Alternatively, it has also been 
shown that laurate [12] and unsaturated long chain 
fatty acids [15] can inhibit type I metabolism in
microsomes. The inhibition by laurate was competi- 
tive with and therefore probably selective for type I 
Table 1 
Conditions 
% of control 
cytochrome P-450 
remaining 
% of control 
lipid phosphorus 
remaining 
Microsomes incubated 
with pancreatic lipase 
Microsomes incubated 
with pancreatic lipase 
and 20 mg/ml fatty 
acid-free BSA 
Rough microsomes incubated 
with phospholipase C 
Smooth microsomes incubated 
with phospholipase C 
8.0 
70.2 
46.7 
45.2 
33.3 
32.7 
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metabolites and occurred at low fatty acid levels where 
there was no apparent denaturation of cytochrome 
P-450;  whereas the inhibition with unsaturated long 
chain fatty acids was shown to occur at concentrations 
where type II metabolism is unaffected. Thus, it seems 
likely that the inhibition of type I metabolism caused 
by phospholipase C treatment results from a combina- 
tion of direct inhibition and denaturation f cyto- 
chrome P -450  by free fatty acids arising from 
diglyceride lipase activity. 
Finally, it would seem feasible to attempt the 
solubilization of cytochrome P -450  and other 
proteins by treating microsomes first with phospholi- 
pase C and then with a lipase, provided BSA is always 
present in the medium. 
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